Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

LifeStance Expects Q1 Fiscal Year 2024 Revenues Of $287M-$307M, Versus Consensus Of $298.41M, With Center Margin Of $81M-$93M, And Adjusted EBITDA Of $17M-$23M

Author: Benzinga Newsdesk | February 28, 2024 07:16am

Posted In: LFST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist